Perturbations in the blood metabolome up to a decade before prostate cancer diagnosis in 4387 matched case-control sets from the European Prospective Investigation into Cancer and Nutrition.
Journal article
Grenville ZS. et al, (2024), Int J Cancer
Circulating inflammatory and immune response proteins and endometrial cancer risk: a nested case-control study and Mendelian randomization analyses.
Journal article
Wang SE. et al, (2024), EBioMedicine, 108
Cluster effect for SNP-SNP interaction pairs for predicting complex traits.
Journal article
Lin H-Y. et al, (2024), Sci Rep, 14
Identifying proteomic risk factors for overall, aggressive, and early onset prostate cancer using Mendelian Randomisation and tumour spatial transcriptomics.
Journal article
Desai TA. et al, (2024), EBioMedicine, 105
Circulating free insulin-like growth factor-I and prostate cancer: a case-control study nested in the European prospective investigation into cancer and nutrition.
Journal article
Cheng TS. et al, (2024), BMC Cancer, 24
Identifying proteomic risk factors for cancer using prospective and exome analyses of 1463 circulating proteins and risk of 19 cancers in the UK Biobank.
Journal article
Papier K. et al, (2024), Nat Commun, 15
RE: Exploring the cross-cancer effect of circulating proteins and discovering potential intervention targets for 13 site-specific cancers.
Journal article
Yarmolinsky J. et al, (2024), J Natl Cancer Inst, 116, 764 - 765
Identifying therapeutic targets for cancer among 2074 circulating proteins and risk of nine cancers.
Journal article
Smith-Byrne K. et al, (2024), Nat Commun, 15
Circulating endogenous sex steroids and risk of differentiated thyroid carcinoma in men and women.
Journal article
Rinaldi S. et al, (2024), Int J Cancer
Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis.
Journal article
Yarmolinsky J. et al, (2024), EBioMedicine, 100
Observational and genetic associations between cardiorespiratory fitness and cancer: a UK Biobank and international consortia study.
Journal article
Watts EL. et al, (2023), Br J Cancer
Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants.
Journal article
Wang A. et al, (2023), Nat Genet, 55, 2065 - 2074
Dose-response of accelerometer-measured physical activity, step count, and cancer risk in the UK Biobank: a prospective cohort analysis.
Journal article
Shreves AH. et al, (2023), Lancet, 402 Suppl 1
Germline Sequencing Analysis to Inform Clinical Gene Panel Testing for Aggressive Prostate Cancer.
Journal article
Darst BF. et al, (2023), JAMA Oncol, 9, 1514 - 1524
Prediagnostic selenium status, selenoprotein gene variants and association with breast cancer risk in a european cohort study.
Journal article
Hughes DJ. et al, (2023), Free Radic Biol Med
Dietary amino acids and risk of stroke subtypes: a prospective analysis of 356,000 participants in seven European countries.
Journal article
Tong TYN. et al, (2023), Eur J Nutr
Associations of intakes of total protein, protein from dairy sources, and dietary calcium with risks of colorectal, breast, and prostate cancer: a prospective analysis in UK Biobank.
Journal article
Watling CZ. et al, (2023), Br J Cancer, 129, 636 - 647
Intake of the Total, Classes, and Subclasses of (Poly)Phenols and Risk of Prostate Cancer: A Prospective Analysis of the EPIC Study.
Journal article
Almanza-Aguilera E. et al, (2023), Cancers (Basel), 15
Genetic predisposition to metabolically unfavourable adiposity and prostate cancer risk: A Mendelian randomization analysis.
Journal article
Perez-Cornago A. et al, (2023), Cancer Med, 12, 16482 - 16489
Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis.
Journal article
Yarmolinsky J. et al, (2023), Diabetologia, 66, 1481 - 1500